JP2006505290A5 - - Google Patents

Download PDF

Info

Publication number
JP2006505290A5
JP2006505290A5 JP2005506685A JP2005506685A JP2006505290A5 JP 2006505290 A5 JP2006505290 A5 JP 2006505290A5 JP 2005506685 A JP2005506685 A JP 2005506685A JP 2005506685 A JP2005506685 A JP 2005506685A JP 2006505290 A5 JP2006505290 A5 JP 2006505290A5
Authority
JP
Japan
Prior art keywords
peroxiredoxin
fragment
pharmaceutical composition
vihum
prx
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005506685A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006505290A (ja
Filing date
Publication date
Priority claimed from RU2002129774/15A external-priority patent/RU2280448C2/ru
Priority claimed from RU2003123534/13A external-priority patent/RU2250262C1/ru
Application filed filed Critical
Priority claimed from PCT/RU2003/000473 external-priority patent/WO2004043485A1/ru
Publication of JP2006505290A publication Critical patent/JP2006505290A/ja
Publication of JP2006505290A5 publication Critical patent/JP2006505290A5/ja
Pending legal-status Critical Current

Links

JP2005506685A 2002-11-10 2003-11-05 抗酸化医薬化合物、ポリペプチドの産生方法、治療方法 Pending JP2006505290A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2002129774/15A RU2280448C2 (ru) 2002-11-10 2002-11-10 Композиция с антиоксидантными свойствами и способ лечения болезней млекопитающих
RU2003123534/13A RU2250262C1 (ru) 2003-07-29 2003-07-29 РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pET23-a(+)PrxVIhumΔ178, КОДИРУЮЩАЯ N-КОНЦЕВОЙ ФРАГМЕНТ ПЕРОКСИРЕДОКСИНА VI ЧЕЛОВЕКА, И ШТАММ E.coli BL21/DE3/pET23-a(+)/PrxVIhumΔ178 - ПРОДУЦЕНТ N-КОНЦЕВОГО ФРАГМЕНТА ПЕРОКСИРЕДОКСИНА VI ЧЕЛОВЕКА
PCT/RU2003/000473 WO2004043485A1 (en) 2002-11-10 2003-11-05 Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure

Publications (2)

Publication Number Publication Date
JP2006505290A JP2006505290A (ja) 2006-02-16
JP2006505290A5 true JP2006505290A5 (cg-RX-API-DMAC7.html) 2006-12-21

Family

ID=32314175

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005506685A Pending JP2006505290A (ja) 2002-11-10 2003-11-05 抗酸化医薬化合物、ポリペプチドの産生方法、治療方法

Country Status (5)

Country Link
US (1) US8003345B2 (cg-RX-API-DMAC7.html)
EP (1) EP1566182A4 (cg-RX-API-DMAC7.html)
JP (1) JP2006505290A (cg-RX-API-DMAC7.html)
CA (1) CA2505478A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004043485A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010101301A1 (en) * 2009-03-05 2010-09-10 National University Corporation University Of Fukui Prophylaxis and treatment of macular degeneration and retinopathy using a prdx protein
CN102573881A (zh) * 2009-03-20 2012-07-11 通用医疗公司以马萨诸塞州通用医疗公司名义经营 预防和治疗烧伤损伤和继发性并发症的方法
US8859235B2 (en) * 2009-08-14 2014-10-14 Basf Se Methods in cell cultures, and related inventions, employing certain additives
JP5684397B2 (ja) * 2010-10-25 2015-03-11 コリア アトミック エナジー リサーチ インスティテュート 放射線の照射を用いたペルオキシレドキシンのシャペロン活性調節方法
CN102485272A (zh) * 2010-12-06 2012-06-06 李建远 重组人Prx-6蛋白在治疗烧烫伤方面的用途
CN102793911B (zh) * 2011-05-24 2015-12-16 李建远 重组人Prx-6蛋白在治疗角膜损伤方面的用途
WO2012075911A1 (zh) * 2010-12-06 2012-06-14 Li Jianyuan 重组人prx-6蛋白在治疗烧烫伤和/或角膜损伤中的用途
CN103417961B (zh) * 2012-05-23 2018-02-09 烟台聚杰生物工程有限公司 Prdx2和/或prdx6的新用途
CN105211054B (zh) * 2015-11-10 2017-05-24 刘娟 一种含重组人prdx4蛋白的人精液冷冻保护剂

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612214D0 (en) * 1996-06-11 1996-08-14 Mallinckrodt Veterinary Inc Vaccine
CA2285631A1 (en) * 1997-04-02 1998-10-08 The Jackson Laboratory Antioxidant protein 2, gene and methods of use therefor
BE1011331A6 (fr) * 1997-08-20 1999-07-06 Univ Catholique De Louvain Hal Polypeptide associe au peroxysome, sequence nucleotidique encodant ledit polypeptide et leur utilisation dans le diagnostic et/ou le traitement de maladies ou de lesions pulmonaires.
AR042572A1 (es) * 1999-04-02 2005-06-29 Sod Conseils Rech Applic Derivados de acido lipoico, procedimiento para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y utilizacion de dichos derivados para la preparacion de los referidos medicamentos
FR2798672B1 (fr) 1999-09-17 2003-10-31 Commissariat Energie Atomique Formes acides des peroxyredoxines et leur utilisation comme moyen de diagnostic
US20030186839A1 (en) * 2000-08-28 2003-10-02 Akira Awaya Medicinal compositions
US20020168353A1 (en) * 2001-03-23 2002-11-14 Lynn Ralf Geiben Peroxiredoxin drugs for treatment of HIV-1 infection and methods of use thereof
WO2002061063A1 (en) * 2001-01-30 2002-08-08 Universite Catholique De Louvain Crystal structure of peroxiredoxin 5 and its use for design of structural homologues
EP1394182A1 (en) 2002-07-08 2004-03-03 Europroteome AG Agents and methods for diagnosis and therapy of cancer and cancer risk assessment
RU2250262C1 (ru) 2003-07-29 2005-04-20 Институт биоорганической химии им. академиков М.М.Шемякина и Ю.А.Овчинникова РАН РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pET23-a(+)PrxVIhumΔ178, КОДИРУЮЩАЯ N-КОНЦЕВОЙ ФРАГМЕНТ ПЕРОКСИРЕДОКСИНА VI ЧЕЛОВЕКА, И ШТАММ E.coli BL21/DE3/pET23-a(+)/PrxVIhumΔ178 - ПРОДУЦЕНТ N-КОНЦЕВОГО ФРАГМЕНТА ПЕРОКСИРЕДОКСИНА VI ЧЕЛОВЕКА
RU2280448C2 (ru) 2002-11-10 2006-07-27 Институт биофизики клетки РАН Композиция с антиоксидантными свойствами и способ лечения болезней млекопитающих
JP5019878B2 (ja) * 2003-09-20 2012-09-05 エレクトロフォレティックス リミテッド 脳障害関連疾患の診断のためのマーカーの検出に関する方法
KR100569165B1 (ko) 2003-11-14 2006-04-07 (주)아비코아생명공학연구소 닭 퍼옥시레독신 1 단백질 및 그를 코딩하는 핵산분자
KR100605308B1 (ko) 2003-12-01 2006-07-26 전남대학교산학협력단 PrxⅡ 단백질의 혈관 내피세포 탐지용 마아커로서의 용도
WO2005123944A1 (en) * 2004-06-18 2005-12-29 Roche Diagnostics Gmbh Use of protein pdx1 as a marker for breast cancer
KR100953326B1 (ko) 2004-08-31 2010-04-20 이화여자대학교 산학협력단 페록시레독신의 활성검출 키트
KR100610774B1 (ko) * 2005-02-03 2006-08-28 이화여자대학교 산학협력단 퍼록시레독신 2 단백질을 유효성분으로 함유하는 혈관재협착 예방 및 치료용 약학조성물, 퍼록시레독신 2유전자 또는 그로부터 발현되는 단백질을 포함하는 혈관재협착 치료제 스크리닝용 조성물 및 이를 이용하는 혈관재협착 치료제 스크리닝 방법
WO2007140976A2 (en) 2006-06-06 2007-12-13 F. Hoffmann-La Roche Ag Enzymes as biomarker for alzheimer's disease
US20100297673A1 (en) 2006-09-20 2010-11-25 Reddy Us Therapeutics Methods and compositions for upregulation of peroxiredoxin activity
JP2008275413A (ja) 2007-04-27 2008-11-13 Osaka Industrial Promotion Organization 扁平上皮癌の診断用キット及び判定方法

Similar Documents

Publication Publication Date Title
Secombes et al. Cytokines and innate immunity of fish
Lefevre et al. A novel and atypical type one interferon gene expressed by trophoblast during early pregnancy.
US10022435B2 (en) Nucleic acid vaccines
WO2005055948A3 (en) Epha2, epha4 and lmw-ptp and methods of treatment of hyperproliferative cell disorders
TW201406959A (zh) 抗發炎胜肽及包含其之成分(三)
KR20010006534A (ko) Ⅱ형 tgf-베타 수용체/면역글로불린 불변 영역 융합 단백질
CN113563478A (zh) 白介素-4受体结合融合蛋白及其应用
US8377883B2 (en) Peptide for anti-angiogenesis and use thereof
JP2006505290A5 (cg-RX-API-DMAC7.html)
CN101062952B (zh) 由人血清白蛋白和干扰素组成的融合蛋白及其编码基因与应用
WO2004108088A3 (en) Methods and compositions for interferon therapy
JP5221959B2 (ja) 代謝障害の状態を治療するためのil−22の使用
AU2010203446B2 (en) Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22
US10413586B2 (en) Antiviral agent comprising recombinant mistletoe lectins
SK287523B6 (sk) Použitie CC chemokínového mutanta, farmaceutický prostriedok s obsahom chemokínového mutanta, skrátený a mutovaný humánny RANTES a spôsob jeho výroby
CN111848780A (zh) 一种IL-36的可溶性受体sIL-36R及其应用
ITRM950273A1 (it) Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni
CN111777667B (zh) 小肽及其在制备免疫调节药物中的应用
CN108690123B (zh) 短肽在制备免疫调节药物中的应用
US20140038887A1 (en) Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions
WO2002013845A3 (en) Inflammation related g-protein coupled receptor
WO2017101089A1 (zh) 一种α促黑素细胞激素的融合蛋白及其制备方法和应用
US20180326009A1 (en) Glial Cell Line Derived Neurotrophic Factor, Obesity, and Obesity-Related Diseases and Conditions
CN117919385B (zh) IL-37在MERS-CoV感染疾病的治疗中的应用
CN105017406B (zh) 一类新的具有神经保护功能的多肽